Just because it's newer doesn't mean it's better. This is the message to come from recent studies that have examined the therapeutic effects of the latest generation of antipsychotic medications on children and adolescents. Not only are the remedial effects no better than older generation drugs but patients simply appear to swap one set of side... Read more
American society is no more tolerant of schizophrenia than it was a decade ago. A study by Professor of Sociology Jason Schnittker, points to a situation where genetic arguments as the basis for schizophrenia have gained popularity, but traditional fears and attitudes about schizophrenia remain static.
The study is a follow-on... Read more
Meet any two people with Schizophrenia and you will be confronted by an interesting and somewhat puzzling scenario. For a start they will relate entirely different experiences about their condition and most likely will respond entirely differently to their medication - if indeed they respond at all. The course and treatment of... Read more
What's in a name? Well, quite a lot if it happens to be schizophrenia. Public misunderstanding of the term continues to be fuelled by lack of proper education and by media portrayals of the association of schizophrenia with criminality and violence or vaguely disturbing and unreliable behavior.
I was recently drawn to an... Read more
Around 40 percent of people with schizophrenia will have the paranoid type. This is one of five sub-types of schizophrenia. Paranoid schizophrenia tends to appear later in life, usually around the age of 25 to 30. The main features are a preoccupation with one or more delusions or frequent auditory hallucinations, but nothing prominent in... Read more